Oct. 1, 2011
Contact: Donna Appell, President and Founder, HPS Network, (516) 922-4022, or e-mail: email@example.com
FOR IMMEDIATE RELEASE
Yang Zhou wins grant from the HPS Network and ATS Foundation
Oyster Bay, N.Y. – Dr. Yang Zhou, associate research scientist working in Dr. Jack Elias’s lab at the Yale University School of Medicine, has been awarded a grant from the Hermansky-Pudlak Syndrome Network (HPS Network) and the American Thoracic Society Foundation.
Dr. Zhou’s project will investigate a potential biomarker and therapeutic target of pulmonary fibrosis, which may one day lead to better diagnostic and treatment options for patients. Hermansky-Pudlak Syndrome (HPS) is a rare genetic disorder that causes albinism, a bleeding disorder, and in a subset of patients, other health problems such as a Crohn’s-like digestive problem and pulmonary fibrosis. Pulmonary fibrosis is a scarring of the lungs. In patients with HPS, it is ultimately fatal, typically between 30 and 50 years of age. While HPS is rare, it is one of the most common genetic disorders among people of Puerto Rican ancestry.
The HPS Network and the ATS Foundation have partnered to provide the funding for this two-year grant as part of the ATS’s Foundation Research Program.
The HPS Network is a not-for-profit organization, founded in 1992, that offers support to families affected by HPS as well as promotes HPS research. Learn more at: www.hpsnetwork.org.
The ATS Foundation strives to preserve and improve the respiratory health of all people globally through its strategic investments in the full spectrum of research, education and training. The Foundation measures the success of its efforts by the benefits provided to patients, their families and communities worldwide. Learn more at: http://foundation.thoracic.org/